Overview
Sampling of dISF and blood plasma for qualitative measurements.
Description
Sampling of dISF will be performed to investigate biomarkers in dISF for early diagnosis and follow-up of cardiovascular diseases.
Eligibility
Inclusion criteria:
Group 1: Chronic heart failure with stable therapy. NYHA classification III and IV. Age > 60 years. Group 2: Age 18-40 years.
Exclusion criteria:
- Participating in another clinical investigation which may affect the study outcome according to clinical judgement.
- Previous use of sampling system used.
- Pregnancy or lactating.
- Any disease or condition that may be affected.
- Individuals who lack the ability to fully consent to participate in the study.
- Severe skin injury.
- Tattoo or piercing close to sampling area.
- Group 1: All forms of emergency care.
- Group 1: Non-stable therapy.
- Group 1: Sepsis.
- Group 1: BMI > 30kg/m2.
- Group 1: Age > 84 years.
- Group 2: Known heart or vascular disease.
- Group 2: Diabetes.
- Group 2: Kidney disease.